blog.aids.gov − Research Agenda
AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research Agenda

NIH’s Dr. Dieffenbach Shares Final Update from AIDS 2016

Carl Anne Day 3 FB Live - resized

In his third and final update from the International AIDS Conference (AIDS 2016) in Durban, South Africa, NIH’s Dr. Carl Dieffenbach discussed highlights of ongoing HIV cure research presented at the conference. Dr. Dieffenbach, the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), spoke with his colleague…

Vaginal Ring Provides Partial Protection from HIV in Large Multinational Trial

Woman holding the dapivirine vaginal ring tested in the NIH-funded ASPIRE study.
Credit: International Partnership for Microbicides

NIH-Funded Study Finds Protective Effect Strongest in Women over Age 25 A ring that continuously releases an experimental antiretroviral drug in the vagina safely provided a modest level of protection against HIV infection in women, a large clinical trial in four sub-Saharan African countries has found. The ring reduced the risk of HIV infection by…

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2016

croi2016logo

The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) takes place next week in Boston, and AIDS.gov will be there. This annual scientific meeting brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related…

HHS & NIH Seek Public Comments on LGBT Health

HHS Logo

There are two opportunities to offer public comment on plans to better understand and improve the health and wellness of lesbian, gay, bisexual and transgender (LGBT) Americans. These federal plans include but extend beyond HIV, addressing many other health concerns of the LGBT community. NIH LGBT Research Strategic Plan The National Institutes of Health (NIH)…

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic

NIH logo

Extraordinary progress has been made in HIV/AIDS research over the last 34 years, transforming what was once a terrifying and almost inevitably fatal disease into a treatable disorder. People with HIV/AIDS can now experience an almost normal life expectancy if antiretrovirals are started promptly and continued for life. But the disease remains a significant public…

Appreciating Dr. Jack Whitescarver’s Many Contributions to HIV/AIDS Research

photo whitescarver

At the end of this month, we bid a fond farewell to a colleague who has played a key role in leading Federal research efforts in response to HIV/AIDS since the earliest days of the epidemic. As NIH previously announced, on July 1, 2015, Dr. Jack Whitescarver is retiring and stepping down as NIH’s Associate…

NIH’s Dr. Carl Dieffenbach Shares Highlights as CROI 2015 Begins (Video)

croi2015_w280x100

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) got underway in Seattle yesterday, February 23, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He discussed what we can anticipate hearing more about during this annual scientific meeting that brings…

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2015

AIDS.gov

The 2015 Conference on Retroviruses and Opportunistic Infections (CROI)   takes place next week in Seattle, Washington, and AIDS.gov will be there. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS, hepatitis C (HCV), Ebola, and related infectious diseases provides a vital forum for translating laboratory and clinical research into…